Logo.jpg
ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
30 mars 2021 17h10 HE | ProPhase Labs, Inc.
 New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
Logo.jpg
ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
15 mars 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021...
Logo.jpg
ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
01 févr. 2021 08h30 HE | ProPhase Labs, Inc.
Company to Host Business Update Shareholder’s Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time GARDEN CITY, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
Logo.jpg
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE | ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
Logo.jpg
ProPhase Labs, Inc. Announces Closing of Public Offering
21 janv. 2021 16h30 HE | ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
Logo.jpg
ProPhase Labs Announces Proposed Public Offering of Common Stock
15 janv. 2021 17h21 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed...
Logo.jpg
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
05 janv. 2021 12h10 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
Logo.jpg
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
16 nov. 2020 08h30 HE | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
Logo.jpg
ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
02 nov. 2020 08h30 HE | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
Logo.jpg
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30 sept. 2020 17h04 HE | ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...